8/7/2006 | BT | Predix starts phase 2 pulmonary hypertension trial
|
8/3/2006 | BT | Predix expands research collaboration with Cystic Fibrosis Foundation Therapeutics
|
7/31/2006 | BT | Predix, Amgen to collaborate on development of S1P1 modulators for autoimmune diseases
|
7/18/2006 | BT | Predix says studies shows PRX-03140 improves cognitive performance, memory in Alzheimer's disease
|
7/13/2006 | BT | Predix Pharmaceuticals receives milestone payment from Cystic Fibrosis Foundation affiliate
|
6/30/2006 | BT | EPIX files appeal with FDA in response to Vasovist approvable letter
|
6/13/2006 | BT | Predix: Phase 2 study shows PRX-00023 reduces symptoms in generalized anxiety disorder
|
6/7/2006 | BT | Predix begins phase 1 trial of PRX-07034 in obesity
|
5/26/2006 | BT | Market Commentary: Anadys spikes on thin volume; Cubist extends gain on Cubicin nod; Tanox, Momenta, Epix up
|
5/24/2006 | BT | Predix completes enrollment in PRX-00023 anxiety trial
|
5/3/2006 | BT | Predix receives patent on 5-HT receptor antagonists, related treatment of serotonin disorders
|
4/19/2006 | BT | Predix phase 1b study indicates PRX-08066 reduces hypoxia-induced pulmonary blood pressure
|
4/3/2006 | BT | EPIX to acquire Predix in $90 million transaction
|
4/3/2006 | BT | Market Commentary: Epix up 21% on Predix buy; Incyte falls 41%; Medarex off; Inhibitex plunges 66%; StemCells dives
|
11/14/2005 | BT | Predix study indicates PRX-03140 may improve dementia in patients with Alzheimer's
|
10/26/2005 | BT | Predix pulls IPO, blames market conditions
|
10/26/2005 | BT | Market Commentary: NxStage talk sweetened; Predix pulls IPO; Biosite plunges; CV Therapeutics dives; Idenix rises
|
10/21/2005 | BT | Market Commentary: Electro-Optical delays IPO again; Jerini IPO scheduled for Oct. 24 week; Affymetrix off; Cephalon higher
|
10/20/2005 | BT | Market Commentary: Predix IPO put on hold; Amgen spiral continues; Abgenix climbs; generics off despite Tamiflu talks
|
10/20/2005 | BT | Predix Pharma IPO delayed, with pricing now 'to be determined'
|
10/19/2005 | BT | Market Commentary: Predix IPO on deck; Indevus up; Generex up; NeoPharm gains; Amgen plunges; Genta climbs
|
10/14/2005 | BT | Market Commentary: Predix, Electro-Optical IPOs imminent; Durect gains on trial news; Voyager IPO talk seen aggressive
|
9/30/2005 | BT | Predix Pharmaceuticals sets initial IPO price talk at $10-$12 per share
|
9/30/2005 | BT | Market Commentary: Predix IPO price range emerges; Genomic, Avalon, Sunesis a mix; Progenics up; BioDelivery slides
|
8/3/2005 | BT | Predix Pharmaceuticals files to offer $70 million of stock in IPO
|